Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1002_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
26 Мб
Скачать
Chapter 53
Diarrhea After Duodenal Switch: Medical andSurgical Management
BarbaraJ.Allen andPatrickW.Domkowski
Bariatric surgery has emerged as the primary treatment for chronic morbid obesity disease in the United States and the world. The data supporting the health improve­ment and reduction in BMI are indisputable. However as more and more people undergo bariatric surgery, the prevalence of certain sequelae following surgery is also becoming more evident. One of these problems that can have a direct impact on the quality of life is diarrhea. The reasons for it after bariatric surgery are numerous and sometimes challenging to treat.
Chronic diarrhea, although infrequent, can become a debilitating problem for
patients after bariatric surgery and in particular the duodenal switch.
Bariatric surgery does alter bowel function. The effects are in part determined by the type of bariatric surgery performed. The effects of altered bowel function may also be acute, meaning within the rst month of surgery or more chronic in nature, affecting function years later. Diarrhea is one specication manifestation of altered bowel function. Moreover, it has a spectrum of presentation with respect to stool consistency and frequency.
The World Health Organization denes diarrhea as three or more (frequency) loose bowel movement a day. Diarrhea is usually dened as three basic categories: watery, fatty (malabsorptive), and inammatory. For our purposes we will focus on fatty or malabsorptive diarrhea. Diarrhea can also present as a spectrum to several inconvenient loose bowel movements a day to the other extreme of more than 20 watery bowel movements daily with no ability to leave your house.
Despite the signicant effectiveness of the duodenal switch (DS) in ameliorating morbid obesity disease and many of its comorbid conditions, it is yet to be widely adopted by bariatric surgeons or embraced by patients seeking bariatric surgery. The
B. J. Allen · P. W. Domkowski (*) Sebastian River Medical Center, Sebastian, FL, USA e-mail: Barbara.Allen@Steward.org; Patrick.Domkowski@Steward.org
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 A. Teixeira et al. (eds.), Duodenal Switch and Its Derivatives in Bariatric and Metabolic Surgery, https://doi.org/10.1007/978-3-031-25828-2_53
493
494
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
B. J. Allen and P. W. Domkowski
DS is performed in less than 1% of all bariatric surgeries worldwide. When evaluat­ing the risk benet analysis for the DS, many providers and/or patients may be dis­suaded against the procedure due to concerns for diarrhea. This chapter will review the pathophysiology of the DS and its impact on diarrhea. It will also review medi­cal and surgical management of diarrhea postoperatively.
53.1 Diarrhea
Alterations in bowel function can be expected after DS surgery due to the anatomi­cal changes. The average number of bowel movements per day following the DS is 2–3 [1]. Diarrhea is generally accepted to be the passage of three or more loose or liquid stools per day or more frequent passage than is normal for the individual.
Diarrhea is generally considered to be one of the commonly accepted operative risks associated with DS surgery as there is a sixfold increase in diarrhea postopera­tively [2]. DS patients report higher incidence of bowel movements, atus, and urgency [2]. Patients with severe diarrhea may also experience dehydration, nutri­tional deciencies, physical discomfort, and changes in quality of life.
Diarrhea can be acute lasting 1 or 2days, persistent lasting longer than 2weeks but less than 4weeks, or chronic lasting more than 4weeks. Diarrhea can be catego­rized as watery, fatty (malabsorptive), or inammatory. This chapter will focus more on malabsorptive causes of diarrhea. However, when completing your history and physical exam, it is important to consider other sources that may be causing or exacerbating postsurgical diarrhea.
53.2 Pathophysiology ofDuodenal Switch andDiarrhea
The basic anatomical changes associated with the duodenal switch are the restric­tion caused by the sleeve gastrectomy portion of the surgery and alterations in metabolism caused by the biliopancreatic diversion. The sleeve gastrectomy restricts calorie intake and food choices. Because it is pylorus sparing, it is not associated with “dumping syndrome.” There is a decrease in acidity of gastric contents, but the sleeve anatomy generally does not have much impact on bowel function. However, by diverting food from the proximal to the distal gut, there is an impact on intestinal hormone secretion, decreased fat absorption, and creation of short gut syndrome. It is generally accepted that the common channel length of 100cm produces the same weight loss with lesser diarrhea and decreased protein deciency compared to a 50cm common channel [3]. Although it is individually variable, over time the body will naturally improve absorption of fat until it reaches a new equilibrium [3]. Therefore, consideration of surgical intervention for diarrhea is not generally rec­ommended until after the rst year [4].
In normal anatomy, the presence of fat in the duodenum causes the release of the gut hormone, cholecystokinin (CCK), which slows gastric motility and
53 Diarrhea After Duodenal Switch: Medical andSurgical Management
495
emptying, stimulates pancreatic enzymes release, and causes contraction of the gallbladder with subsequent release of lecithin and bile salts [3]. Lipid digestion and absorption is affected by the diversion of the biliopancreatic limb. Shortening of the common channel can lead to incomplete absorption of dietary fat. Excessive levels of bile acids in the lower gastrointestinal tract may cause diarrhea via one or more mechanisms: altering water and sodium transport; increasing lower gastroin­testinal motility; damaging the mucosa; inducing mucus secretion; or stimulating defecation [5]. Fatty acids that are not broken down are passed directly into the colon. Undigested fat leads to lose and frequent bowel movements that may be often hard to control and associated with cramping, foul-smelling diarrhea, and lots of gas.
The diversion of the biliopancreatic limb also affects digestion of starches and complex carbohydrates. Decreased exposure to amylase in the GI tract decreases the time that carbohydrates can be broken down into simple sugars for absorption. In normal anatomy, starch exposed to pancreatic and digestive enzymes is nearly completely hydrolyzed before it has passed beyond the duodenum and the upper jejunum [3]. Many patients report onset of lactose intolerance following bariatric surgery. Incomplete carbohydrate absorption can lead to an increased osmotic load of sugar, with an augmented intraluminal volume (water) and a consequent accel­eration of intestinal passage. Gas production and diarrhea occur in connection with the bacterial ora in the colon, the unabsorbed sugar presenting as a substrate for increased bacterial fermentation [6]. Ingestion of sugar alcohols which are not well absorbed in the GI tract can also lead to fermentation and subsequent GI upset with bloating, gas, and diarrhea. The most common forms are sorbitol, mannitol, xyli­tol, and maltitol. The microvilli of the small intestine further digest starch and other dietary carbohydrates. Over time, the GI tract can compensate with thicker and more efcient villi to counteract the malabsorption and decrease GI symp­toms. Another factor contributing to diarrhea is the presence of relatively undi­gested food passing rapidly through the gastrointestinal tract creating irritation in the ileum [4].
There is reason to believe that bariatric surgery including the DS alters the neu­ronal and hormonal signaling pathways that regulate pancreatic secretions. The symptoms of pancreatic exocrine insufciency (PEI) steatorrhea, weight loss, mal­digestion, and malabsorption are expressed in both patient populations. Although clinical studies are lacking, it is appropriate to consider pancreatic enzyme replace­ment therapy in the management of post DS diarrhea [7].
53.2.1 Evaluation ofDiarrhea
53.2.1.1 History
Evaluation relies heavily on the patient history. Have the patient describe the onset of symptoms, frequency, and consistency of the stool as well as other associated symptoms like urgency, fever, bloating, abdominal pain, blood, or mucus in the
496
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
B. J. Allen and P. W. Domkowski
stool. Patients with diarrhea often report fatigue, dizziness, nausea, unplanned weight loss, low urine output, or concentrated urine. Include dietary history and look for potential triggers like sugar alcohols, fatty foods, caffeine, and alcohol. Ask about recent travel and employment (daycare worker, food handler). Review medi­cation list for drugs commonly associated with diarrhea. Do not forget to assess the impact symptoms have on the patient’s quality of life. Having three bowel move­ments a day has a different impact on an ofce worker versus an over the road truck driver. Some patients report meal skipping behaviors because eating triggers diarrhea.
53.2.2 Physical Exam
The primary focus of the physical exam is to assess for evidence of dehydration, malabsorption, or its sequela. Alterations in general appearance (lethargy), skin turgor, mucous membranes, and vital signs (include orthostatic vitals) are signs of dehydration related to diarrhea. Evidence of muscle wasting, hair loss, ascites, ecchymoses (vitamin K deciency), temporal wasting, angular cheilitis, glossitis, and peripheral edema is indicative of malabsorption. A general abdominal exam is warranted especially if there are complaints of abdominal pain to rule out an acute abdominal process. If the patient is experiencing neuromuscular signs of muscle weakness or convulsions, severe electrolyte abnormalities are to be suspected.
53.2.3 Testing
It is reasonable to suspect malabsorption in patients with diarrhea following the DS. The most frequent causes are protein, fat, and carbohydrate malabsorption. However, chronic or persistent diarrhea following the DS could be related to de­ciency in zinc or selenium ([8, 9], p.197). While there is no specic serologic test for malabsorption, laboratory tests are helpful to identify specic deciencies or complications from malabsorption as well as other potential causes of diarrhea. Based on patient history and physical exam, laboratory testing may include CBC, CMP, prealbumin, vitamin B12, folate, 25-hydroxyvitamin D, lipid panel, prealbu­min, prothrombin time, carotene, methylmalonic acid, zinc, and selenium. Refer to Table53.1 for serologic lab testing.
Stool specimens may be helpful to evaluate diarrhea related to surgical malab­sorption and to rule out other causes (Table53.2). Stool tests can be utilized to docu­ment fat malabsorption, which is the most sensitive indicator among the macronutrients to identify global malabsorption. Fecal fat can be performed by
53 Diarrhea After Duodenal Switch: Medical andSurgical Management
Table 53.1 Serologic lab testing
Test Evaluate for Findings
CBC Anemia due to iron deciency or
vitamin B12 or folate deciency
Serum iron, total iron binding capacity
Vitamin B12, folate Vitamin deciency Decreased CMP Protein deciency, electrolyte
Magnesium Malabsorption Decreased Prealbumin Malnutrition Decreased Lipid panel Malabsorption Decreased—cholesterol,
Carotene Fat malabsorption Decreased 25-Hydroxyvitamin D Fat malabsorption vitamin D Decreased Prothrombin time Fat malabsorption vitamin K Increased Methylmalonic acid Early indicator of vit. B12
Zinc Malabsorption Decreased Selenium Malabsorption Decreased
Iron deciency Decreased
imbalances, and organ function
deciency
Microcytic anemia—iron deciency Macrocytic anemia—vit B12 or folate malabsorption Dehydration—hematocrit elevated
Protein malabsorption— decreased protein, albumin, calcium Dehydration—elevated BUN/Cr, potassium, sodium Diarrhea—decreased potassium, sodium, magnesium, CO
triglycerides
Increased
497
2
completing a qualitative assessment on a single specimen or a quantitative analysis that requires 72-h fecal fat collection. Instruct patients to consume a normal amount (80–100g/day) of fat before and during the collection. A fecal fat excretion of >7g/ day indicates fat malabsorption or pancreatic exocrine insufciency (PEI).
The hydrogen breath test can be used to detect carbohydrate malabsorption as well as small intestine bacterial overgrowth. Glucose hydrogen breath test is more acceptable for diagnosis of small intestinal bacterial overgrowth (SIBO), whereas lactose and fructose hydrogen breath tests are used for detection of lactose and fruc­tose maldigestion, respectively [9].
Sometimes Zollinger Ellison’s syndrome (ZES) presents with diarrhea and no other symptoms. If this is suspected at a gastrin level 10 times, the normal ndings are suggestive of ZES and require further workup.
It is important to remember that patients with a DS have normal gastric empty­ing. This was studied. They found that over 80% of patients had normal gastric emptying.
498
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Table 53.2 Stool specimen testing
Test fecal Evaluate for Findings
Culture If bacterial infection is suspected Bacteria
Clostridium difcile toxin
Ova and parasites Ova and parasites suggested for
Fecal occult blood
Stool for white Inammatory intestinal disease Positive Fecal calprotectin Inammation Elevated in inammatory bowel
Fecal fat—qualitative
Fecal fat— quantitative (72-h collection)
Elastase PEI Decreased
Clostridium difcile especially for patients with diarrhea after hospitalization or following antibiotic therapy
those with a history of travel or camping
Suspected malignancy Positive
Fat malabsorption Positive
Fat malabsorption or PEI Greater than 7g/day
B. J. Allen and P. W. Domkowski
Campylobacter species
Salmonella species
Shigella species Positive
Positive
disease, bacterial infections, some parasitic infections, and colorectal cancer Decreased in irritable bowel syndrome and viral infections
53.3 General Management ofDiarrhea
The goals of management include treating the underlying disease, optimizing the control of diarrhea, identifying and treating nutritional deciencies, monitoring for recurrence, and optimizing quality of life.
53.3.1 Medical Management ofDiarrhea Related
toNutrient Malabsorption
• Have patients complete a food diary and symptom tracker to identify trig-
ger foods.
• Serum laboratory testing to evaluate for dehydration and determine degree of
malabsorption as well as vitamin and mineral deciencies. Serum laboratory
testing will also be completed to monitor patient progress (Table53.1).
53 Diarrhea After Duodenal Switch: Medical andSurgical Management
499
• Consider testing to conrm the source of malabsorption (fecal fat, hydrogen
breath test, lactose tolerance test) (Table53.2).
• Nutritional consult for dietary education based on above ndings.
• Nutritional support to ensure appropriate protein (80–120 g/day) and
caloric intake:
– Oral nutrition is preferred with food and/or protein shakes. – In severe cases, parenteral or enteral supplementation may be warranted. Use
caution when initiating high concentrations of dextrose to prevent refeeding syndrome.
– If prolonged parenteral or enteral supplementation is required, surgical inter-
vention is considered.
• Ensure adequate hydration:
– Water, sugar-free sports drinks, non-caffeinated beverages. – IV hydration is especially helpful when diarrhea is severe or is associated
with nausea and vomiting. Infuse normal saline and consider infusing a banana bag (multivitamin, thiamine, folic acid) if indicated. Do not infuse dextrose until a thiamine deciency is ruled out.
• Replacement of vitamin and mineral deciencies.
• Exocrine pancreatic insufciency:
– Pancrelipase microencapsulated, delayed release (e.g., creon). Initially 30,000
USP units lipase with meals and half of that amount with snacks; adjust grad­ually to patient needs. Recommended for patients with intact upper GI tract and intact gastric secretions.
– Pancrelipase, non-microencapsulated (e.g., Viokace). Initially 30,000 USP
units lipase with meals and half of that amount with snacks; adjust gradually to patient needs. Inactivated by stomach acid. Use in patients lacking acid­peptic gastric environment or administered with acid-suppressing drugs ([10], p.11).
• Bile acid malabsorption is usually determined through empirical treatment and
resolution of symptoms rather than through testing:
– Cholestyramine 4 g once daily initially; increase gradually (weekly) to four
divided doses; maximum, 36g/day ([10], p.11).
– Please note there is a potential for reduced absorption of other drugs and
supplements, and therefore cholestyramine should be administered either 1h before or 4–6h after other medications.
– Unfortunately, use of cholestyramine for chronic diarrhea due to bile acid
malabsorption is currently an off-label use and is not always covered by insurance.
• Antidiarrheals can be used to slow transit time and assist with symptom
management:
500
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
B. J. Allen and P. W. Domkowski
– Begin with loperamide and advance to diphenoxylate and atropine if needed. – A dose of loperamide at bedtime can decrease the number of early morning
bowel movements. It may also delay the onset in those who have been previ­ously awakened early in the morning by urgent bowel movements [4].
– Caution patients that cases of torsades de pointes, cardiac arrest, and death
have been reported with the use of a higher than recommended dosage of loperamide.
• Small intestinal bacterial overgrowth:
– The use of antibiotics to treat the symptomatic patient with SIB0 is the cor-
nerstone of therapy ([11], p.172).
Ciprooxacin and metronidazole are commonly used. Amoxicillin–clavulanic acid, doxycycline, and trimethoprim–sulfa­methoxazole may also be considered. Rifaximin use is limited by its high cost.
– Nutritional support and correction of nutritional deciencies is an important
step in managing SIBO since it is not only associated with malabsorption but can cause malabsorption and vitamin deciencies ([11], p.170).
– Although a diet low in fermentable oligo-, di-, and monosaccharides and
polyols (FODMAP) has been shown to improve bloating and gas in patients with irritable bowel syndrome, there is no strong evidence to support its rec­ommendation in patients with SIBO.
– It is common practice to consider probiotics in the treatment of SIBO.Although
a small study on Roux-en-Y gastric bypass surgery patients supported the use of probiotics to improve bacterial overgrowth [12], the use of probiotics in the duodenal switch patient is largely empiric.
53.3.2 Patient Education
Having 2–3 bowel movements a day is considered normal.
Complete a food diary and symptom tracker to help identify dietary causes of diarrhea. There are even downloadable apps that can help track dietary intake and bowel patterns. Use of dietary tracking apps to monitor intake of macronutrients (carbohydrates, fats, ber, proteins, and water) provides data that can help with symptom management and self-care.
Restrict fat to less than 50 g/day.
Whenever possible, eliminate or avoid trigger foods. Ingest triggers foods with or after other foods to increase tolerance.
Read labels to avoid sugar alcohols (sorbitol, mannitol, xylitol, and maltitol).
If lactose intolerant, consider lactose-free milk or addition of lactase. Lactase should be taken with your rst bite of food or drink.
53 Diarrhea After Duodenal Switch: Medical andSurgical Management
501
Use quality protein supplements as needed to meet a protein goal of 80–120 g daily. Whey isolate protein supplements have little to no lactose. Don’t drink pro­tein shakes too fast.
Avoid more than one serving a day of caffeine containing beverages.
Avoid full strength sugar sweetened beverages. If consumed dilute with water in a 1:1 ratio.
Compliance with nutritional supplements and lab monitoring is critical to pre­venting/managing nutritional deciencies and therefore diarrhea.
Stay hydrated. The general recommendation of maintaining hydration with 64 ounces of uid daily may not be adequate in the presence of high-water loss with diarrhea. If additional uids are needed, consider supporting electrolytes with a sugar-free sports drink.
53.3.2.1 Surgical Treatment ofDiarrhea
The biliopancreatic diversion (BPD) with the duodenal switch (DS) as described by Hess and Hess in 1998 remains one of the most effective bariatric surgeries for short- and long-term reduction in body mass index as well as amelioration of type II diabetes, one of the diseases most commonly associated with obesity disease [13]. However due to its technical difculties and purported post-surgical nutri­tional deciencies, it has yet to be widely adapted into mainstream bariatric surger­ies. Among these side effects are possible protein malnutrition and diarrhea. As reported in the original paper by Hess and Hess in 1998, the length of the common channel was between 50 and 100cm. This is why it is critical for the DS patient to consume 90–100 g of protein daily.
If diarrhea persists even after both dietary modications and prescription medi­cations have been exhausted, then surgical revision may be an option. There are several case reports in the literature of patients that have had successful elimination of their diarrhea through revisionary surgery.
However, it is important to note that the perception that the duodenal switch may cause more frequent bowl habits compared to other bariatric surgeries is not true. A study by Wasserberg and colleagues compared the bowel habits of gastric bypass patients to duodenal switch patients. Although the duodenal switch is associated with more bowel episodes than the bypass, the difference was not statistically sig­nicant [14]. Fysekidis and colleagues reported that the average number of bowel movements per day for 43 pre-op patients was 1.9 [15]. Postoperatively the fre­quency of bowel habits was measured at different time intervals and compared with preoperative values. Six months after surgery, the average number was 2.7. Twelve months following surgery that was 2.6 and 36months was 2.8. None of these mea­sured time points were signicantly different to the preoperative number.
In another study, Sovik and colleagues did a comparative study on the duodenal switch and the gastric bypass effects on bowel habits [16]. They had followed up at 1 and 2 years after surgery, and participants were surveyed. They reported an
502
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
B. J. Allen and P. W. Domkowski
increase in both the amount of bowel habits and anal leakage following the switch compared to the gastric bypass.
The concept of revising a bariatric surgery due to refractory diarrhea is not unique to the duodenal switch. Revisional surgeries have also been in gastric bypass patients. In 2012, Appresai and Murr reported the lengthening of the common chan­nel in a gastric bypass patient suffering with chronic diarrhea and decreased quality of life [17]. The patient had an original distal gastric bypass with a 150cm reported common channel. At the time of the revisionary surgery, 50 additional centimeters was switched from the biliopancreatic limb to the alimentary limb. This ameliorated the diarrhea and returned the patients serum albumin to above 3 g/dL.Therefore, the length of the common channel and thus the absorptive intestinal surface area appears to be the chief determinant in frequency of diarrhea.
This has been reported with “very very long” limb bypasses where the common channel is shorter [18]. Nelson and colleagues reported this name for their surgery. The Roux limb was made between 300 and 500cm with a 100cm common channel that the incidence of diarrhea signicantly and negatively impacting the quality of life was 4%. All of these patients required surgical revision to increase the length of the common channel 100–200cm. This surgical maneuver increases the absorptive capacity of the small intestine, thereby increasing serum albumin and water absorp­tion, thus leading to less diarrhea. Physiologically, this increases the surface area of absorption and thereby effectively eliminates the diarrhea in these refractory cases. The fact that there are only case reports in the surgical literature speaks to their rarity.
Conceptually the surgery involves lengthening the common channel. However, it is by denition considered revisional bariatric surgery and therefore must be under­taken with an even greater level of hyper vigilance. Most importantly, the intestinal limbs must be correctly identied before anything transacted and re-anastomosed. In the BPD-DS, this would include identifying the alimentary limb, the biliopancre­atic limb, and the common intestinal channel. Typically, the common intestinal channel in the DS is between 50 and 100cm in length. Increasing it to 150–200cm will generally increase absorption of nutrients enough to eliminate the diarrhea.
A variation of the traditional duodenal switch is the single anastomosis duode­noileal bypass with sleeve gastrectomy (SADI-S) [19]. This is a potentially a prom­ising alternative to the traditional duodenal switch with purported less gastrointestinal sequel. Nonetheless, a concern of this variation is the chronic diarrhea and potential hypoproteinemia. A single site experience reported a 6-year experience with the SADI-S.Horsey and colleagues reported a signicantly reduced number of average bowel movements from 9 to 2.6 with common channel lengthening with the SADI-S.Since this is a loop switch, the duodenal ileostomy has to be redone.
As reected in the published literature, the vast majority of patients with diarrhea can be managed medically through a combination or dietary modications and medications. In those refractory cases, surgery can be performed to decrease malab­sorption by returning more small bowel intestinal length to the food stream.